Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs

Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programmes around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline-based drugs is becoming critical...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Microbiol
Autori principali: Mok, Sachel, Liong, Kek-Yee, Lim, Eng-How, Huang, Ximei, Zhu, Lei, Preiser, Peter Rainer, Bozdech, Zbynek
Natura: Artigo
Lingua:Inglês
Pubblicazione: BlackWell Publishing Ltd 2014
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286016/
https://ncbi.nlm.nih.gov/pubmed/24372851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/mmi.12505
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi